Skip to main content

ORIGINAL RESEARCH article

Front. Digit. Health
Sec. Personalized Medicine
Volume 6 - 2024 | doi: 10.3389/fdgth.2024.1485508

A Novel, Machine-Learning Model for Prediction of Short-Term ASCVD Risk Over 90 and 365 Days

Provisionally accepted
Tomer Gazit Tomer Gazit 1*Hanan Mann Hanan Mann 1Shiri Gaber Shiri Gaber 1Pavel Adamenko Pavel Adamenko 1Granit Pariente Granit Pariente 1Liron Volsky Liron Volsky 1Amir Dolev Amir Dolev 1Helena Lyson Helena Lyson 1Eyal Zimlichman Eyal Zimlichman 2Jay Pandit Jay Pandit 3Edo Paz Edo Paz 1
  • 1 Hello Heart, Menlo Park, United States
  • 2 Sheba Medical Center, Ramat Gan, Tel Aviv District, Israel
  • 3 Scripps Translational Science Institute, The Scripps Research Institute, La Jolla, California, United States

The final, formatted version of the article will be published soon.

    Background: Current atherosclerotic cardiovascular disease (ASCVD) risk assessment tools like the Pooled Cohort Equations (PCEs) and PREVENT TM scores offer long-term predictions but may not effectively drive behavior change. Short-term risk predictions using mobile health (mHealth) data and electronic health records (EHRs) could enhance clinical decision-making and patient engagement. The aim of this study was to develop a short-term ASCVD risk prediction model for hypertensive individuals using mHealth and EHR data and compare its performance to existing risk assessment tools.Methods: This is a retrospective cohort study including 51,127 hypertensive participants aged ≥18 years old who enrolled in the Hello Heart CV risk self-management program between January 2015 and January 2024. A machine learning (ML) model was derived from EHR data and mHealth measurements of blood pressure (BP) and heart rate (HR) collected via at-home BP monitors. Its performance was compared to that of PCE and PREVENT.The XgBoost model incorporating 291 features outperformed the PCE and PREVENT scores in discriminating ASCVD risk for both prediction periods. For 90-day prediction, mean C-statistics were 0.81 (XgBoost) vs. 0.74 (PCE) and 0.65 (PREVENT). Similar findings were observed for 365-day prediction. mHealth measurements incrementally enhanced 365-day risk prediction (ROC-AUC 0.82 vs. 0.80 without mHealth).An EHR and mHealth-based ML model offers superior short-term ASCVD prediction compared to traditional tools. This approach supports personalized preventive strategies, particularly for populations with incomplete features for PCE or PREVENT. Further research should explore this novel risk prediction framework, and particularly additional mHealth data integration for broader applicability and increased predictive power.

    Keywords: machine learning, Cardiovascular Risk Assessment, Personalized preventive strategies, mobile health, Digital health technology

    Received: 23 Aug 2024; Accepted: 11 Oct 2024.

    Copyright: © 2024 Gazit, Mann, Gaber, Adamenko, Pariente, Volsky, Dolev, Lyson, Zimlichman, Pandit and Paz. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Tomer Gazit, Hello Heart, Menlo Park, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.